Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Receivables (2020 - 2025)

Definitive Healthcare's Receivables history spans 6 years, with the latest figure at $54.0 million for Q4 2025.

  • For Q4 2025, Receivables fell 3.65% year-over-year to $54.0 million; the TTM value through Dec 2025 reached $54.0 million, down 3.65%, while the annual FY2025 figure was $54.0 million, 3.65% down from the prior year.
  • Receivables reached $54.0 million in Q4 2025 per DH's latest filing, up from $34.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $59.4 million in Q1 2024 to a low of $1.2 million in Q4 2021.
  • Average Receivables over 5 years is $36.3 million, with a median of $39.7 million recorded in 2022.
  • Peak YoY movement for Receivables: plummeted 96.39% in 2021, then soared 2396.62% in 2024.
  • A 5-year view of Receivables shows it stood at $1.2 million in 2021, then surged by 40.08% to $1.7 million in 2022, then soared by 33.61% to $2.2 million in 2023, then skyrocketed by 2396.62% to $56.1 million in 2024, then decreased by 3.65% to $54.0 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Receivables are $54.0 million (Q4 2025), $34.8 million (Q3 2025), and $38.0 million (Q2 2025).